Medical Device

Holter ECG Market – Drawing the Competitive Strategy for Improved ROI

A Holter ECG monitor is a wearable device that helps track the heart’s proper functioning. This device is used to conduct a Holter test, especially on an individual susceptible to developing cardiovascular disease. The individual then wears the device for around two to three days, and the heart’s activity is tracked down. The data obtained is downloaded to the central system and analyzed with the help of analysis software, which helps the doctors to suggest an appropriate treatment for the patient.

General Electric Co and Koninklijke Philips NV – are Notable Market Players in Global Holter ECG Market

Leading companies operating in the global Holter ECG market have undertaken various organic and inorganic growth strategies. The global Holter ECG market comprises FUKUDA DENSHI; General Electric Co; EB Neuro SPA; Koninklijke Philips NV; Viatom Technology Co., Ltd.; Nihon Kohden Corp; OSI Systems, Inc.; Hill Rom Holding Inc. (Baxter); BPL Medical Technologies; and SCHILLER Americas Inc. The companies have been implementing various strategies that have helped their growth and, in turn, brought about several breakthroughs and transitions in the industry. The companies have utilized organic strategies such as product launches in the global Holter ECG market, resulting in the market’s growth. Moreover, the market players have also deployed several inorganic strategies, including mergers & acquisitions and collaborations that helped the Company to strengthen its revenue, which allows the Company to hold a strong position in the market.

Below are the major growth strategies undertaken by the players operating in the global Holter ECG market:

YEAR

NEWS

Jan-2022

Royal Philips introduced the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company’s cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.

Nov-2021

Philips has signed an agreement to acquire Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology. This acquisition strengthens Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis, and reporting services.

May-2021

Spacelabs Healthcare a division of OSI Systems, Inc. launched Lifescreen Pro event screening system to diagnose cardiac arrhythmias accurately and economically. Lifescreen Pro expands the Company’s non-invasive cardiology offerings.